VALN - Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June | Benzinga
Saint-Herblain (France), June 4, 2024 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that management will participate at several upcoming investor conferences in the United States and Europe during June 2024.
Valneva will present and meet with global institutional investors to discuss VLA15, the world's leading Lyme Disease vaccine candidate, in Phase 3 development and partnered with Pfizer; the Company's growing commercial business, including ongoing launch plans for IXCHIQ®, the world's first and only approved chikungunya vaccine; and VLA1601, its second-generation Zika virus vaccine candidate, currently in Phase 1 clinical development.
Institutional investors who would like to meet 1on1 with management at any of the below conferences are asked to submit a request to their representative at the respective bank.
Jefferies Global Healthcare Conference
Date/time: June 6, 2:00pm
Format: Fireside chat and investor meetings
Webcast: https://wsw.com/webcast/jeff302/valn/1846928. A replay of the webcast will be available following the live events in the "Investor" section of the Valneva website.
Location: New York, NY
13th ODDO BHF Nextcap Forum
Date: June 6
Format: Investor meetings only
Location: Virtual
Goldman Sachs 45th Annual Global Healthcare Conference:
Date June 10 – 13
Format: Fireside chat and investor meetings
Location Miami, FL
Stifel 2nd European Healthcare Summit
Date: June 25 ...